The remaining subtypes consist of cutaneous CD30+ lymphoproliferative disorders (LPDs) involving primary cutaneous anaplastic large cell lymphoma and lymphomatoid papulosis that account for approximately 25% of CTCL, making CD30+ LPDs the second most frequent subtype. This evidence concerns the gene TNFRSF8 and anaplastic large cell lymphoma.